FOXO TECHNOLOGIES INC. Deferred Leasing Commissions
FOXO TECHNOLOGIES INC. (FOXO) had Deferred Leasing Commissions of $7.04 million as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Notes
us-gaap:DeferredLeasingCommissions · last filed 2021-08-16
- 2021-06-30: Deferred Leasing Commissions $7.04M.
- 2021-03-31: Deferred Leasing Commissions $7.04M.
- 2020-12-31: Deferred Leasing Commissions $7.04M.
| Period end | Deferred Leasing Commissions |
|---|---|
| 2021-06-30 | $7.04M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $7.04M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $7.04M 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |